LopeRA

Randomised controlled trial of laparoscopic, open and robot assisted prostatectomy as treatment for organ confined prostate cancer.

Disease site: Urological cancers Prostate cancer

Treatment Modality: Surgery

Status: In follow-up

Trial details

LopeRA is currently a feasibility study.

The primary endpoint is the success of recruitment and randomisation. The aim is to recruit 75 patients in a 12 month period (e.g. between the 12th and 24th month after all centres have been open to recruitment). In total it is planned that more than 100 patients will be recruited to the trial. Secondary endpoints include clinical and patient-orientated outcomes and compliance.

Patients with organ-confined prostate cancer become eligible for the trial once they have decided on surgical treatment. All recruited patients will be randomly assigned to receive either open, laparoscopic or robot assisted radical prostatectomy.

Ultimately, results from a phase III study will provide evidence as to whether the proposed advantages of minimally invasive techniques translate into improved oncological, clinical and quality of life outcomes. In addition, results will provide evidence to support cost effectiveness of each approach.

Chief Investigator: Professor the Lord Ara Darzi, Imperial College, London

ICR-CTSU Scientific Lead: Dr Emma Hall

Trial management contact: Deborah Piercy - Trial Manager, [email protected]

ISRCTN: 59410552

Sponsor: Imperial College London

Funding: Cancer Research UK (CRUK/09/008)

Further information

Further information on the LopeRA trial may be found on the following sites:

View LopeRA on the National Institute for Health Research website: NIHR - Be Part Of Research

Patient friendly information on the LopeRA trial at CancerHelp UK

Publications and presentations

Mayer E, Piercy D, Kerr K, Lewis R, Griffin C, Cohen D, Corbishley C, Vale J, Hall E, Darzi A. November, ed. Randomised controlled trial (RCT) of Laparascopic, OPEn and robot- assisted prostatectomy as treatment for organ-confined prostate cancer. LopeRA feasibility study. NCRI National Cancer Conference; 2011; Liverpool.

Mayer EK, Piercy D, Cohen DC, Kerr K, Lewis R, Corbishley C, Hall E, Vale JA, Darzi A, and on behalf of the LOPERA Trial Management Group. Randomised controlled trial of laparoscopic open and robot assisted prostatectomy as treatment for organ-confined prostate cancer. The Hamlyn Symposium on Medical Robotics; 2010; London. Imperial College.

breast cancer cell
Major trial shows prolonged benefit of olaparib in early-stage inherited breast cancer

12/12/24

One year of treatment with the targeted drug olaparib improves long-term survival in women with high-risk, early-stage breast cancer with mutations in BRCA1 or BRCA2 genes, new results from a major clinical trial show.
See full story
Breast cancer cell spheroid blue and purple
New understanding of aggressive form of breast cancer paves the way for tests and treatments

10/12/24

Scientists have developed a machine learning tool that can predict how an aggressive type of breast cancer will respond to treatment, and when it will return.
See full story